MCID: SYS071
MIFTS: 37

Systemic Autoimmune Disease

Categories: Bone diseases, Rare diseases

Aliases & Classifications for Systemic Autoimmune Disease

MalaCards integrated aliases for Systemic Autoimmune Disease:

Name: Systemic Autoimmune Disease 58

Classifications:

Orphanet: 58  
Rare systemic and rhumatological diseases


External Ids:

Orphanet 58 ORPHA182228

Summaries for Systemic Autoimmune Disease

MalaCards based summary : Systemic Autoimmune Disease is related to autoimmune disease of endocrine system and autoimmune disease of musculoskeletal system. An important gene associated with Systemic Autoimmune Disease is RPL7 (Ribosomal Protein L7), and among its related pathways/superpathways are IL-17 Family Signaling Pathways and Tuberculosis. The drugs Abatacept and rituximab have been mentioned in the context of this disorder. Affiliated tissues include t cells, b cells and bone, and related phenotypes are immune system and digestive/alimentary

Related Diseases for Systemic Autoimmune Disease

Diseases related to Systemic Autoimmune Disease via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 466)
# Related Disease Score Top Affiliating Genes
1 autoimmune disease of endocrine system 31.5 IL6 IL17A AIRE
2 autoimmune disease of musculoskeletal system 31.3 IL6 IL17A CRP
3 celiac disease 1 31.1 IL6 IL17A CRP AIRE
4 alpha/beta t-cell lymphopenia with gamma/delta t-cell expansion, severe cytomegalovirus infection, and autoimmunity 30.8 IL17A AIRE
5 vasculitis 30.3 IL6 IL17A CRP
6 pneumocystosis 30.1 IL6 CRP
7 systemic scleroderma 30.0 IL6 IL17A CRP
8 scleritis 30.0 MMP9 CRP
9 pyuria 29.8 IL6 CRP
10 acute transverse myelitis 29.8 MMP9 IL6
11 parotitis 29.7 MMP9 CRP
12 cryptogenic organizing pneumonia 29.7 MMP9 CRP
13 atherosclerosis susceptibility 29.7 MMP9 IL6 CRP
14 adult-onset still's disease 29.6 IL6 CRP
15 spondylitis 29.6 IL6 IL17A CRP
16 psoriatic arthritis 29.5 IL6 IL17A CRP
17 cerebrovascular disease 29.4 MMP9 IL6 CRP
18 demyelinating disease 29.4 MMP9 IL6 IL17A
19 temporal arteritis 29.3 IL6 IL17A CRP
20 neutropenia 29.3 IL6 FCGR3A CRP
21 aortic aneurysm 29.3 MMP9 IL6 CRP
22 chorioamnionitis 29.3 MMP9 IL6 CRP
23 iridocyclitis 29.2 IL6 IL17A CRP
24 endocarditis 29.2 IL6 IL17A CRP
25 cystitis 29.2 IL6 IL17A CRP
26 myelitis 29.1 MMP9 IL6 IL17A
27 crohn's disease 29.1 IL6 IL17A CRP
28 peripheral nervous system disease 29.1 IL6 IL17A CRP
29 keratitis, hereditary 29.1 MMP9 IL6 IL17A
30 behcet syndrome 29.1 IL6 IL17A CRP
31 lung disease 29.1 MMP9 IL6 IL17A CRP
32 candidiasis 29.1 IL6 IL17A AIRE
33 alopecia areata 29.1 IL6 IL17A AIRE
34 bronchiolitis 29.0 IL6 IL17A CRP
35 relapsing polychondritis 29.0 IL6 IL17A CRP
36 aspiration pneumonia 29.0 IL6 IL17A CRP
37 panuveitis 29.0 IL6 IL17A CRP
38 interstitial lung disease 29.0 MMP9 IL6 IL17A CRP
39 cholangitis 28.9 IL6 IL17A CRP
40 transverse myelitis 28.9 MMP9 IL6 IL17A
41 ulcerative colitis 28.9 IL6 IL17A CRP
42 spondyloarthropathy 28.8 IL6 IL17A FCGR3A
43 kawasaki disease 28.8 MMP9 IL6 IL17A CRP
44 pneumonia 28.7 MMP9 IL6 IL17A CRP
45 bacterial infectious disease 28.7 IL6 IL17A FCGR3A CRP
46 collagen disease 28.6 RPL7 IL6 IL17A CRP
47 hashimoto thyroiditis 28.6 IL6 IL17A CRP AIRE
48 eye disease 28.6 MMP9 IL6 IL17A CRP
49 bronchiolitis obliterans 28.4 MMP9 IL6 IL17A CRP
50 periodontitis 28.4 MMP9 IL6 IL17A CRP

Graphical network of the top 20 diseases related to Systemic Autoimmune Disease:



Diseases related to Systemic Autoimmune Disease

Symptoms & Phenotypes for Systemic Autoimmune Disease

MGI Mouse Phenotypes related to Systemic Autoimmune Disease:

45
# Description MGI Source Accession Score Top Affiliating Genes
1 immune system MP:0005387 9.7 AIRE CRP FCGR2B IL17A IL6 MAN2A1
2 digestive/alimentary MP:0005381 9.65 AIRE FCGR2B IL17A IL6 MMP9
3 renal/urinary system MP:0005367 9.35 FCGR2B IL17A IL6 MAN2A1 MMP9
4 respiratory system MP:0005388 9.1 AIRE FCGR2B IL17A IL6 MAN2A1 MMP9

Drugs & Therapeutics for Systemic Autoimmune Disease

Drugs for Systemic Autoimmune Disease (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 106)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Abatacept Approved Phase 4 332348-12-6 10237
2
rituximab Approved Phase 4 174722-31-7 10201696
3 Antirheumatic Agents Phase 4
4 Immunologic Factors Phase 4
5 Immunosuppressive Agents Phase 4
6 Antineoplastic Agents, Immunological Phase 4
7
Hydroxychloroquine Approved Phase 3 118-42-3 3652
8
Cyclophosphamide Approved, Investigational Phase 3 50-18-0, 6055-19-2 2907
9
Methylprednisolone Approved, Vet_approved Phase 3 83-43-2 6741
10
Acetaminophen Approved Phase 3 103-90-2 1983
11
Prednisolone Approved, Vet_approved Phase 3 50-24-8 5755
12
Methylprednisolone hemisuccinate Approved Phase 3 2921-57-5
13 Prednisolone acetate Approved, Vet_approved Phase 3 52-21-1
14
Prednisolone phosphate Approved, Vet_approved Phase 3 302-25-0
15
Clemastine Approved, Investigational Phase 3 15686-51-8 26987
16
Granisetron Approved, Investigational Phase 3 109889-09-0 3510
17 Coconut Approved Phase 3
18
Ergocalciferol Approved, Nutraceutical Phase 3 50-14-6 5280793
19
Vitamin D Approved, Nutraceutical, Vet_approved Phase 3 1406-16-2
20
Vitamin D3 Approved, Nutraceutical Phase 3 67-97-0 6221 5280795
21
Calcium Approved, Nutraceutical Phase 3 7440-70-2 271
22
Prednisolone hemisuccinate Experimental Phase 3 2920-86-7
23 Antiparasitic Agents Phase 3
24 Antiprotozoal Agents Phase 3
25 Antimalarials Phase 3
26 Immunoglobulins Phase 3
27 Antibodies Phase 3
28 Hormone Antagonists Phase 3
29 Alkylating Agents Phase 3
30 Antiemetics Phase 3
31 Gastrointestinal Agents Phase 3
32 Methylprednisolone Acetate Phase 3
33 Neuroprotective Agents Phase 3
34 Protective Agents Phase 3
35 Autonomic Agents Phase 3
36 Antineoplastic Agents, Hormonal Phase 3
37 Anti-Inflammatory Agents Phase 3
38 glucocorticoids Phase 3
39 Antibodies, Antineutrophil Cytoplasmic Phase 3
40 Hormones Phase 3
41 Vitamins Phase 3
42 Trace Elements Phase 3
43 Micronutrients Phase 3
44 Nutrients Phase 3
45 Ergocalciferols Phase 3
46 Calciferol Phase 3
47 Calcium, Dietary Phase 3
48 Vitamin D2 Phase 3
49
Clopidogrel Approved Phase 1, Phase 2 120202-66-6, 113665-84-2 60606
50
Methotrexate Approved Phase 2 1959-05-2, 59-05-2 126941

Interventional clinical trials:

(show all 43)
# Name Status NCT ID Phase Drugs
1 Abatacept for the Treatment of Refractory Juvenile Dermatomyositis Recruiting NCT02594735 Phase 4 Abatacept
2 Maintenance of ANCA Vasculitis Remission by Intermittent Rituximab Dosing Based on B-cell Reconstitution vs a Serologic ANCA Flare Recruiting NCT02749292 Phase 4 Rituximab
3 Randomized, Double-blind, Placebo-controlled Trial of Hydroxychloroquine in Primary Sjögren's Syndrome Completed NCT00632866 Phase 3 Hydroxychloroquine;Placebo
4 A Randomized, Double-blind, Parallel, Placebo-controlled Trial to Evaluate the Efficacy of Tocilizumab for the Treatment of Primary Sjögren's Syndrome. Completed NCT01782235 Phase 2, Phase 3 Tocilizumab;Placebo
5 Randomized, Double-blind, Placebo-controlled Phase III Study to Assess the Efficacy and Safety of Abatacept in Patients With Primary Sjögren's Syndrome (ASAP III Study = Abatacept Sjögren Active Patients Phase III Study) Completed NCT02067910 Phase 3 Abatacept SC
6 Evaluating Favorable, Immunological Effects of Rituximab With Cyclophosphamide Compared to Rituximab Alone in AAV Patients Recruiting NCT03942887 Phase 3 Rituximab;endoxan;Methylprednisolone;Prednisolone
7 Vitamin D3 Supplementation in Polymorphic Light Eruption: Randomized Double-blinded Placebo-controlled Trial Terminated NCT01595893 Phase 3 Oral Vitamin D 3;Miglyol 812 N
8 A Phase 2, Proof of Concept, 52-Week Open Study to Evaluate the Efficacy and Safety of Belimumab (HGS1006, LymphoStat-B™), a Fully Human Monoclonal Anti-BLyS (BAFF) Antibody, in Subjects With Primary Sjögren's Syndrome Completed NCT01160666 Phase 2 Belimumab
9 Pilot Study Related to the Effect of Clopidogrel on Plasmatic Soluble CD40 Ligand During Systemic Lupus Erythematous Completed NCT02320357 Phase 1, Phase 2 Treatment by clopidogrel
10 A Phase II, Randomised, Double-blind, International, Multicentre, Placebo-controlled, Dose-ranging, Parallel-group Study to Evaluate the Efficacy and Safety of Orally Administered Rob 803 When Added to Stable Methotrexate Completed NCT00525213 Phase 2 Rob 803;Placebo
11 Pilot Study of Thalidomide for Sjogren's Syndrome Completed NCT00001599 Phase 2 Thalidomide
12 A Phase 2, Proof of Concept, 52-Week Open Study to Evaluate the Efficacy and Safety of Belimumab (HGS1006, LymphoStat-B™), a Fully Human Monoclonal Anti-BLyS Antibody, in Subjects With Primary Sjögren's Syndrome. Completed NCT01008982 Phase 2 LimphoStat-B
13 A Pilot Study of Intensified Lymphodepletion Followed by Autologous Hematopoietic Stem Cell Transplantation in Patients With Severe Systemic Lupus Erythematosus Completed NCT00076752 Phase 2 fludarabine phosphate;cyclophosphamide;methylprednisolone;Diphenhydramine;Mesna
14 A Randomized Trial to Investigate the Reset of Humoral Autoimmunity by Combining Belimumab With Rituximab in Severe Systemic Lupus Erythematosus Recruiting NCT03747159 Phase 2 Belimumab Injection
15 Phase I/II Study of Immunotherapy Combination BN-Brachyury Vaccine, M7824, ALT-803 and Epacadostat (QuEST1) Recruiting NCT03493945 Phase 1, Phase 2 ALT-803;Epacadostat
16 A Randomized Placebo-controlled, Double Blind Phase 2 Clinical Trial of Levocarnitine for the Treatment of Keratoconjunctivitis Sicca in Sjogren's Syndrome Not yet recruiting NCT03953703 Phase 2 Levocarnitine;Placebo
17 A Phase I/II Study of Nonmyeloablative Conditioning and Transplantation of Human Leukocyte Antigen (HLA)-Matched, Partially HLA-mismatched, HLA-haploidentical or Matched Unrelated Bone Marrow for Patients With Refractory SLE Terminated NCT02080195 Phase 1, Phase 2 Cyclophosphamide;Fludarabine;Tacrolimus;Mycophenolate Mofetil;Rabbit antithymocyte globulin
18 Abatacept for Patients With Inflammatory Arthritis Associated With Sjögren's Syndrome: an Open-Label Phase II Study Withdrawn NCT02027298 Phase 2 Abatacept
19 An Open Label Phase I Study to Evaluate the Safety and Tolerability of GI-6301 Vaccine Consisting of Whole, Heat-Killed Recombinant Saccharomyces Cerevisiae (Yeast) Genetically Modified to Express Brachyury Protein in Adults With Solid Tumors Completed NCT01519817 Phase 1
20 First In-Human Phase I Trial of NHS-IL12 in Patients With Metastatic Solid Tumors Recruiting NCT01417546 Phase 1 NHS-IL-12
21 Diagnostic Value of Antibodies Against a Modified Citrullinated Vimentin in Patients With Rheumatoid Arthritis Unknown status NCT03265236
22 Role of DcR3 in T Cell Activation in SLE and RA Unknown status NCT00275899
23 Molecular Reclassification to Find Clinically Useful Biomarkers for Systemic Autoimmune Diseases: Inception Cohort Unknown status NCT02890134
24 Study of the Role of Soluble Forms of RAGE (sRAGE/esRAGE) as Diagnostic and Prognostic Biomarkers of Systemic Lupus Erythematosus. Unknown status NCT02891213
25 Duke Autoimmunity in Pregnancy Registry Completed NCT00513591
26 The Effect of Ethanol Extract Physalis Angulata Linn. in Scleroderma Patients With Standard Therapy to Reduce Skin Fibrosis Based on Modified Rodnan Skin Score, Reduce Inflammation, Immunological Response and Fibrosis Completed NCT03141125
27 Effect of Qi Gong Training on Quality of Life in Patients With Systemic Lupus Erythematous (LuQi) Completed NCT02732470
28 Patient Interviews to Better Understand Disease Experience and Unmet Treatment Needs in Rheumatoid Arthritis Completed NCT03285191
29 Study During Pregnancy of miRNAs in Rheumatoid Arthritis or Systemic Lupus Erythematosus Completed NCT02350491
30 Exercise-induced Improvements of Inflammatory Status in Patients With Rheumatoid Arthritis - Improvements of Cardiovascular Risk Factors and Quality of Life Completed NCT01478334
31 Systemic Lupus Erythematosus in Gullah Health Recruiting NCT00756769
32 Duke Lupus Registry Recruiting NCT00512694
33 Risk Factors for Thrombosis in Immune Thrombocytopenia Recruiting NCT03820960
34 Dietary Phytoestrogens in Blood and Urine of Female Patient With Acute Systemic Lupus Erythematosus Recruiting NCT03421184
35 Assessment of Systemic Complications (Signs) and Evolution From Patients With Sjögren's Syndrome (ASSESS) Recruiting NCT03040583
36 The DRAIHA Study: Data Registry of AutoImmune Hemolytic Anemia, to Improve Diagnostic Testing for the Development of Personalized Treatment Protocols in AIHA Patients Recruiting NCT04024202
37 Department of Nursing, Dalin Tzuchi Hospital Recruiting NCT03446989
38 The Colonic Microbiome and Mucosal Immunity in Inflammatory Bowel Disease and Ankylosing Spondylitis Enrolling by invitation NCT02389075
39 Chemokine CXCL13 as a Marker of Disease Activity in Systemic Lupus Erythematosus Not yet recruiting NCT03752983
40 Autophagy Genes and Interleukin-10 in Systemic Lupus Erythematosus Patients Not yet recruiting NCT03583853
41 Ocular Comorbidities of Alopecia Areata Not yet recruiting NCT03155958
42 Involvement of Immune Cells Derived From the Intestine in Sjogren's Syndrome Not yet recruiting NCT03841318
43 Finger-prick Autologous Blood (FAB) for Use in Dry Mouth Not yet recruiting NCT03530735

Search NIH Clinical Center for Systemic Autoimmune Disease

Genetic Tests for Systemic Autoimmune Disease

Anatomical Context for Systemic Autoimmune Disease

MalaCards organs/tissues related to Systemic Autoimmune Disease:

40
T Cells, B Cells, Bone, Lung, Skin, Thyroid, Heart

Publications for Systemic Autoimmune Disease

Articles related to Systemic Autoimmune Disease:

(show top 50) (show all 1530)
# Title Authors PMID Year
1
Design of an anti-inflammatory diet (ITIS diet) for patients with rheumatoid arthritis. 61
32025586 2020
2
Altered ciliary morphofunction in the oviductal infundibulum of systemic autoimmune disease-prone MRL/MpJ-Faslpr/lpr mice. 61
32025875 2020
3
Autoimmune Autonomic Disorders. 61
31996621 2020
4
Antiphospholipid syndrome and infertility. 61
31829084 2020
5
Intra-articular injection of indomethacin-methotrexate in situ hydrogel for the synergistic treatment of rheumatoid arthritis. 61
31930243 2020
6
Sex Differences in Systemic Lupus Erythematosus: Epidemiology, Clinical Considerations, and Disease Pathogenesis. 61
32029091 2020
7
Theacrine alleviates chronic inflammation by enhancing TGF-β-mediated shifts via TGF-β/SMAD pathway in Freund's incomplete adjuvant-induced rats. 61
31791581 2020
8
Seronegative antiphospholipid syndrome: refining the value of non-criteria antibodies for the diagnosis and clinical management. 61
32001534 2020
9
Toward better outcomes in Sjögren's syndrome: The promise of a stratified medicine approach. 61
32005417 2020
10
Interleukin-21-mediated suppression of the Pax3-Id3 pathway exacerbates the development of Sjögren's syndrome via follicular helper T cells. 61
31491724 2020
11
MicroRNA let-7g-5p improves murine collagen-induced arthritis by inhibiting Th17 cell differentiation. 61
31987855 2020
12
Follow-Up of the Libby, Montana Screening Cohort: A 17-Year Mortality Study. 61
31714372 2020
13
Pamidronate in Treatment of Calcinosis in Juvenile Dermatomyositis. 61
31937708 2020
14
CD22 and CD72 contribute to the development of scleroderma in a murine model. 61
31883832 2020
15
Sensitivity and specificity of Interleukin 29 in patients with rheumatoid arthritis and other rheumatic diseases. 61
31954799 2020
16
[Case of a Сombination of Lupus Erythematosus, Antiphospholipid Syndrome and Myocardial Infarction]. 61
31849316 2019
17
Familial Clustering of Antiphospholipid Syndrome. 61
31839101 2019
18
Recent findings regarding the effects of microRNAs on fibroblast-like synovial cells in rheumatoid arthritis. 61
31770498 2019
19
What's new in obstetric antiphospholipid syndrome. 61
31808896 2019
20
Expression of membrane-bound human leucocyte antigen-G in systemic sclerosis and systemic lupus erythematosus. 61
31848026 2019
21
Anti-Cytokine Autoantibodies in Systemic Lupus Erythematosus. 61
31892200 2019
22
Ultrasound versus magnetic resonance imaging in the evaluation of shoulder joint pathologies in a cohort of rheumatoid arthritis patients. 61
31670481 2019
23
Biologic discontinuation strategies and outcomes in patients with rheumatoid arthritis. 61
31663390 2019
24
Is Early Progression to Bilateral Involvement in Menière's Disease a Poor Prognostic Indicator? 61
31613834 2019
25
Primary Antiphospholipid Antibody Syndrome Complicated with Cerebellar Hemorrhage and Aortic Dissection: A Case Report. 61
31822651 2019
26
The effect of patient compliance on remission rates in pediatric noninfectious uveitis. 61
31678259 2019
27
The pathogenesis of systemic lupus erythematosus: Harnessing big data to understand the molecular basis of lupus. 61
31806421 2019
28
Post-translational modifications of proteins in antiphospholipid antibody syndrome. 61
31448653 2019
29
Inflammatory cytokines shape a changing DNA methylome in monocytes mirroring disease activity in rheumatoid arthritis. 61
31371305 2019
30
Nanoparticle-delivered siRNA targeting Bruton's tyrosine kinase for rheumatoid arthritis therapy. 61
31495833 2019
31
MicroRNAs in rheumatoid arthritis: From pathogenesis to clinical impact. 61
31520804 2019
32
Effects of autophagy on apoptosis of articular chondrocytes in adjuvant arthritis rats. 61
31508906 2019
33
Glucocorticoid-sensitive Paroxysmal Atrial Fibrillation, Sick Sinus Syndrome, and Mitral Regurgitation in a Patient with Malignant Rheumatoid Vasculitis. 61
31292399 2019
34
An update on the genetics of systemic lupus erythematosus. 61
31436585 2019
35
Primary Sjogren's syndrome presenting as autoimmune cytopenia. 61
31949888 2019
36
Economic Impact Analysis of the Use of Anti-DFS70 Antibody Test In Patients with Undifferentiated Systemic Autoimmune Disease Symptoms. 61
31676692 2019
37
Epigenetic perspectives on systemic autoimmune disease. 61
31421964 2019
38
Systemic autoimmune disease among adults exposed to the September 11, 2001, terrorist attack. 61
31762219 2019
39
Predictive markers of lymphomagenesis in Sjögren's syndrome: From clinical data to molecular stratification. 61
31431317 2019
40
Association of HLA-DRB1 genotype with younger age onset and elder age onset rheumatoid arthritis in Japanese populations. 61
31770283 2019
41
In-Hospital Mortality-associated Factors in Patients With Thrombotic Antiphospholipid Syndrome Requiring ICU Admission. 61
31783015 2019
42
Clinical Characteristics and Outcomes of Ocular Cicatricial Pemphigoid: A Cohort Study and Literature Review. 61
31356420 2019
43
Increased risks of psychiatric disorders in patients with primary Sjögren's syndrome-a secondary cohort analysis of nationwide, population-based health claim data. 61
31372849 2019
44
Vitamin D status in patients with systemic lupus erythematosus (SLE): A systematic review and meta-analysis. 61
31520805 2019
45
Intracranial Inflammatory Pseudotumor Associated with Idiopathic Hypertrophic Pachymeningitis Mimicking Malignant Tumor or High-Grade Meningioma. 61
31704361 2019
46
Targeting Granulocyte-Monocyte Colony-Stimulating Factor Signaling in Rheumatoid Arthritis: Future Prospects. 61
31486005 2019
47
IgA Nephropathy-Associated Uveitis: A Case Presentation. 61
31580182 2019
48
Assessment of Aortic Stiffness in Patients with Rheumatoid Arthritis Using Pulse Wave Velocity: An Update Meta-analysis. 61
31760330 2019
49
Identification of differentially expressed genes in primary Sjögren's syndrome. 61
31125139 2019
50
Cross-Talk between Mitochondrial Dysfunction-Provoked Oxidative Stress and Aberrant Noncoding RNA Expression in the Pathogenesis and Pathophysiology of SLE. 61
31635056 2019

Variations for Systemic Autoimmune Disease

Copy number variations for Systemic Autoimmune Disease from CNVD:

7
# CNVD ID Chromosome Start End Type Gene Symbol CNVD Disease
1 21054 1 156500000 165500000 Duplication FCGR3B Systemic autoimmune disease

Expression for Systemic Autoimmune Disease

Search GEO for disease gene expression data for Systemic Autoimmune Disease.

Pathways for Systemic Autoimmune Disease

GO Terms for Systemic Autoimmune Disease

Biological processes related to Systemic Autoimmune Disease according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 inflammatory response GO:0006954 9.56 IL6 IL17A FCGR2B CRP
2 acute-phase response GO:0006953 9.32 IL6 CRP
3 regulation of neuroinflammatory response GO:0150077 9.16 MMP9 IL6
4 immune response GO:0006955 9.02 IL6 IL17A FCGR3A FCGR2B AIRE
5 negative regulation of lipid storage GO:0010888 8.96 IL6 CRP

Molecular functions related to Systemic Autoimmune Disease according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 IgG binding GO:0019864 8.62 FCGR3A FCGR2B

Sources for Systemic Autoimmune Disease

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
43 MeSH
44 MESH via Orphanet
45 MGI
48 NCI
49 NCIt
50 NDF-RT
53 NINDS
54 Novoseek
56 OMIM
57 OMIM via Orphanet
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 TGDB
70 Tocris
71 UMLS
72 UMLS via Orphanet
Content
Loading form....